Total planned funding: $843,131,246
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $163,422,535 |
Nigeria | $130,870,621 |
Uganda | $109,521,623 |
Tanzania | $98,960,385 |
Zambia | $84,827,981 |
Mozambique | $41,764,018 |
Côte d'Ivoire | $40,075,015 |
Zimbabwe | $31,842,222 |
Rwanda | $29,775,421 |
South Africa | $27,942,376 |
Vietnam | $25,408,275 |
Haiti | $17,680,002 |
Democratic Republic of the Congo | $10,745,355 |
Ukraine | $8,800,000 |
Eswatini | $6,578,711 |
Botswana | $5,935,437 |
Ethiopia | $3,774,817 |
Guyana | $2,121,954 |
South Sudan | $1,829,817 |
Namibia | $939,798 |
Dominican Republic | $100,000 |
Cameroon | $69,354 |
Papua New Guinea | $57,440 |
Burundi | $50,000 |
Central Asia Region | $26,020 |
Malawi | $12,069 |
Organizational Types
Private Contractor | $622,585,240 |
Host Country Government Agency | $93,121,837 |
Unknown | $48,181,211 |
NGO | $44,059,142 |
Implementing Agency | $24,763,040 |
University | $3,777,286 |
FBO | $3,382,295 |
Own Agency | $2,187,569 |
Parastatal | $1,073,626 |
Program Areas
Treatment | $843,131,246 |
Budget Codes
HTXD: Treatment: ARV Drugs | $843,131,246 |
Top Partner Programs
Chemonics International:
$428,756,235
View countries